Please Contribute Here to help us Grow!
Good healthcare is about people, not paperwork.
When families think about the health system, they are not usually thinking about policy frameworks or organisational charts. They are thinking about whether they can see a doctor when they need one, whether their child can get treatment, whether an elderly parent will be cared for, and whether a diagnosis will come quickly enough.
For many people, health is deeply personal. Families often support children, parents, and grandparents at the same time. When someone becomes seriously unwell, the whole family feels it. That is why practical improvements in healthcare matter so much.
The best health policy is the kind people can actually feel in their lives.
One recent example is Pharmac’s decision to widen access to life-changing cystic fibrosis medicines: Trikafta, Kalydeco, and Alyftrek.
Cystic fibrosis is a serious inherited condition that mainly affects the lungs and digestive system. For families living with it, treatment can make an enormous difference. These medicines can help improve lung function, slow the damage caused by the disease, and give children a better start in life.
Widening access means more people will be able to receive treatment earlier, when it is clinically appropriate. For a child, that can mean more time at school, more time with family, and a better chance of growing up with stronger health. For parents, it can mean more certainty and hope for the future.
That is what people want from the health system. Real help delivered when it matters.
There is also important progress in genomic testing for cancer and rare disorders. Health New Zealand is launching a new two-year pilot so more advanced testing can be done here in New Zealand, rather than sending so many samples overseas.
This matters because waiting for answers can be one of the most stressful parts of serious illness.
For someone with cancer, genomic testing can help doctors better understand the disease and make treatment decisions sooner. For a family dealing with a rare or inherited disorder, testing can help provide answers after months or even years of uncertainty.
New Zealand currently sends thousands of genomic tests overseas each year. The new pilot will process more than 6,000 samples over two years and help build local expertise in genomic medicine. It will also help New Zealand develop secure systems to manage sensitive health data here at home.
This is a smart investment in the future. Modern healthcare is becoming more personalised. The more we understand a person’s condition, the better chance doctors have of choosing the right care at the right time.
Another important change is the decision to move more authority within Health New Zealand closer to regions, districts, hospitals, and communities.
From 1 July, Health New Zealand’s regions and districts will have greater responsibility for staffing, budgets, and service delivery. That means local health leaders will have more ability to respond when demand changes, rather than waiting for every decision to be made centrally.
This matters in a large and diverse city like Auckland. Health services across Auckland are delivered through different districts, including Counties Manukau in the south and east, Auckland, and Waitematā in the north and west. Each area faces different pressures, and local leaders are often best placed to understand what their hospitals and communities need.
Leadership at the national level will still matter. New Zealand still needs clear standards, strong planning, and a health system that works together. But practical decisions about services and resources should be made as close as possible to the patients and communities they affect.
That is how we build a health system that is more responsive, more practical, and more focused on people.-Dr Parmjeet Parmar